Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-04 · accession 0001062993-24-005758 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-06 | 2024-03-05 | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $3.43 | -48.7K | 2.58M | -2% | -$167.0K |
| 2024-03-06 | 2024-03-04 | ADPT | ROBINS CHAD M | CEO, COB, Dir | A - Grant | $0.00 | +354.6K | 2.63M | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-05 | S | D | 5,879 | $3.44 | 2,619,495 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-05 | S | D | 42,794 | $3.43 | 2,576,701 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-04 | A | A | 354,610 | $0.00 | 2,625,374 | D | — | — |